From left, Hydra Hydra Biosciences President and CEO Russell Herndon; Hydra Founder, Professor at Children’s Hospital Boston, Harvard Medical School and Howard Hughes Investor David Clapham, MD, PhD; Providence ABC6 Anchor Karen Meyers; Patient Pain Advocate Cindy Steinberg; Analgesic Solutions Founder and President Nathaniel Katz, MD; and former Massachusetts Department of Public Health Commissioner Cheryl Bartlett
PAIN: a conversation panel discussion drew nearly 100 clinicians, scientists, patient advocates, patients, investors and biotech/pharma industry professionals on October 22 at the Liberty Hotel in Boston to discuss the critical need for new treatment options for patients with chronic pain and the related and increasing problem of opioid dependence and addiction. The panelists emphasized that in conjunction with new treatments, better training of medical professionals in diagnosing and treating pain is critical in order to bring hope to people suffering daily, while reducing the escalating problem of opioid addiction. Lots of people nowadays go for the easier option of taking cannabis in various different forms to ease their chronic pain, a good place to start if you’d like to do more research is somewhere like https://www.canadacannabisdispensary.ca/. Another prominent issue is those who are suffering as a result of an accident that wasn’t their fault, as they’re also processing the injustice of the situation, but the answer to this is not to rely on intoxicants, but to take legal action. Don’t sit and think ‘but when should you hire a car accident lawyer?‘ for example, if you’re in pain as a result of it, you have a claim. At least this is an option for victims of accidents, but for those with no one else to blame, dangerous medication can seem like the only route to relief.
The forum received praise from several attendees for its unique interdisciplinary approach to the related problems. Today, Hydra also is releasing A Conversation with Betsy Navarro, a video produced for the forum detailing one patient�s battle with severe chronic neuropathic pain.
�This cross-functional and inclusive discussion is critical for finding solutions for pain management and ultimately a cure for chronic pain,� said Russell Herndon, President and CEO of Hydra Biosciences. �We were pleased to bring together leaders from science, medicine, advocacy and public health to elevate the conversation on this important topic, but this has to be the first conversation of many. We�d like to invite others to get involved as well.�
Panelist Cindy Steinberg, National Director of Policy and Advocacy for the U.S. Pain Foundation, said, �There is a lack of understanding that chronic pain is a disease itself � a neurobiological disease that we do not understand � regardless of the original cause. There is a lack of research funding, lack of pain management education for physicians and a dearth of new treatment options. We�re still treating patients with trial and error and haven�t made any substantial progress over the last 15 years in finding effective solutions for chronic pain. I�m so pleased to have been a part of this event because it provides hope for people with chronic pain.�
The panel also included Nathaniel Katz, M.D., neurologist and pain specialist as well as founder and President of Analgesic Solutions; Cheryl Bartlett, former Commissioner of the Massachusetts Department of Public Health and current Executive Director of the Cape Cod Regional Substance Abuse Prevention Initiative and Public Health at Cape Cod Health; and David Clapham, M.D., Ph.D., founder of Hydra, Professor of Cardiology at Children�s Hospital Boston, Harvard Medical School and Howard Hughes Investigator.
Also, see related coverage:
Fighting Opioid Abuse With Innovation; Using Non-Addictive Treatment Options